LeonaBio (LONA) Share-based Compensation (2019 - 2026)

LeonaBio (LONA) has 8 years of Share-based Compensation data on file, last reported at $662000.0 in Q1 2026.

• On a quarterly basis, Share-based Compensation fell 59.56% year-over-year to $662000.0 in Q1 2026; TTM through Mar 2026 was $5.2 million, a 48.37% decrease from a year earlier, with the FY2025 full-year figure at $6.1 million, down 44.77% from the prior year.
• Share-based Compensation for Q1 2026 stood at $662000.0, down from $1.5 million in the prior quarter.
• Over the last five years, Share-based Compensation for LONA reached as high as $6.2 million in Q2 2025 and fell as low as $662000.0 in Q1 2026.
• Historically, Share-based Compensation has averaged $2.6 million across 5 years, with a median of $2.5 million in 2023.
• Across the five-year window, Share-based Compensation soared 180.39% in 2022 and plunged 59.56% in 2026, its largest moves.
• Year by year, Share-based Compensation stood at $2.4 million in 2022, then declined by 5.59% to $2.2 million in 2023, then advanced by 0.04% to $2.2 million in 2024, then slumped by 34.59% to $1.5 million in 2025, then sank by 54.6% to $662000.0 in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $662000.0 in Q1 2026, $1.5 million in Q4 2025, and $1.4 million in Q3 2025.